Abstract:Praxisrelevante Änderungen der Leitlinie 2023 Änderung der Indikation zur Durchführung einer Knochendichtemessung, das Zeitintervall, über das das Frakturrisiko bestimmt wird, die Höhe und Anzahl an Therapieschwellen sowie die Empfehlungen zum therapeutischen Vorgehen, die an das individuell vorliegende Frakturrisiko angepasst sind. Risikofaktoren und imminentes Frakturrisiko Der Erfassung des Sturzrisikos wird deutlich mehr Aufmerksamkeit geschenkt und je nach Ergebnis mit Empfehlungen zum Muskeltraining und der Proteinaufnahme ab dem Alter von 65 Jahren kombiniert. Risikoindikatoren sind bei der Indikationsstellung für eine Osteoporosediagnostik zusätzlich zu berücksichtigen wie auch die Risikofaktoren des imminenten Frakturrisikos. Osteoporosediagnostik Die Indikation zur Basisdiagnostik hat sich vom >20%-igen 10-Jahres-Frakturrisiko zu einer Diagnostik bei Frauen nach Eintritt der Menopause und bei Männern ab dem Alter von 50 Jahren abhängig vom Frakturrisikofaktorenprofil geändert. Eine spezifische Frakturrisikoschwelle zur Basisdiagnostik entfällt damit. Neue Schwellenwerte als Indikation für die Einleitung einer Therapie ist die Bestimmung des Frakturrisikos mittels Risikorechner über 3 Jahre anstelle von 10 Jahren. Die Indikationsstellung zur medikamentösen Therapie sollte anhand der Schwellenwerte des DVO-Risikomodells erfolgen. Neue Empfehlungen zur osteoanabolen Therapie Die Aufteilung in Risikogruppen ermöglicht die Identifizierung von Betroffenen mit sehr hohem Frakturrisiko. Die anabole Therapie ist in erster Sequenz in Fällen eines sehr stark erhöhten Frakturrisikos ab 10%/3 Jahre mit osteoanabol-wirksamen Substanzen (Teriparatid oder Romosozumab) empfohlen. Eine solche Therapiesequenz soll direkt eingeleitet werden und nicht wegen anstehender zahnärztlicher Eingriffe verzögert werden. Die Anschlusstherapie zur Konsolidierung der Frakturrisikosenkung ist individuell zu wählen. In September 2023, the guideline on the prophylaxis, diagnosis, and treatment of osteoporosis in postmenopausal women and men was published as a completely revised guideline. The implications for practice include a change in the justifying indication for performing a bone density measurement, the time interval over which the fracture risk is determined, the level and number of therapy thresholds, and the recommendations for the therapeutic approach that are adapted to the individual fracture risk present. Risk assessment for the prediction of spine and hip fractures is essential in the context of osteoporosis diagnostics. In addition to age and gender, there are a total of 33 risk factors to determine the individual risk of fracture. Much more attention is paid to the assessment of the risk of falls and, depending on the result, combined with recommendations for muscle training and protein intake from the age of 65. Risk indicators must also be taken into account when determining the indication for osteoporosis diagnosis, as well as the risk factors of the imminent risk of fracture. The indication for baseline diagnostics has changed from the >20% 10-year fracture risk to diagnostics in postmenopausal women and in men aged 50 years and older, depending on the fracture risk factor profile. This eliminates a specific fracture risk threshold for basic diagnostics. Thus, in the young patient group (50–60 years), the risk factors considered medically relevant for the indication for osteoporosis diagnosis must be taken into account. New thresholds as an indication for initiating therapy is the determination of fracture risk using a risk calculator over 3 years instead of 10 years. The indication for drug therapy should be based on the threshold values of the DVO risk model. The data clearly suggests a significantly faster and more effective fracture risk-reducing effect of anabolic therapy. This is recommended in the first sequence in cases of a very high risk of fracture from 10%/3 years with osteoanabolic active substances (teriparatide or romosozumab). Such a therapy sequence should be initiated directly and not delayed due to upcoming dental procedures. Follow-up therapy to consolidate the reduction of fracture risk should be chosen individually. Article published online: 23 May 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

Development and Evaluation of the OF Pelvis Score for Osteoporotic Pelvic Ring Fractures - A Retrospective Assessment of Therapy Recommendations for 107 Patients

OF-Pelvis classification of osteoporotic sacral and pelvic ring fractures

Therapeutic Prediction of Osteoporotic Vertebral Compression Fracture Using the AO Spine-DGOU Osteoporotic Fracture Classification and Classification-Based Score: A Single-Center Retrospective Observational Study

Special orthopaedic geriatrics (SOG) - a new multiprofessional care model for elderly patients in elective orthopaedic surgery: a study protocol for a prospective randomized controlled trial of a multimodal intervention in frail patients with hip and knee replacement

Early Operative Versus Nonoperative Treatment of Fragility Fractures of the Pelvis: A Propensity-Matched Multicenter Study

Streamlining the Journey of Research Into Clinical Practice: Making Your Patients and Practice Flourish Optimizing Management and Minimizing Risk of Osteoporotic Vertebral Fractures – Perspectives of the AO Spine KF Trauma and Infection Group Key Opinion Leaders

Inter- and intraobserver reliabilities and critical analysis of the osteoporotic fracture classification of osteoporotic vertebral body fractures

Clinical and Patient-Related Outcome After Stabilization of Dorsal Pelvic Ring Fractures: A Retrospective Study Comparing Transiliac Fixator (TIFI) and Spinopelvic Fixation (SPF)

Osteoporose – Implikation der neuen Leitlinie in die Praxis

The influence of pelvic tilt on sacral insufficiency fracture occurrence: Insights into the prevalence of high pelvic tilt among patients affected

GeriNOT im KIS zur systematischen Identifikation geriatrischer Risikopotentiale bei stationärer AkutaufnahmeGeriNOT in the Surgical Inpatient Setting

Georg Schmorl prize of the German spine society (DWG) 2022: current treatment for inpatients with osteoporotic thoracolumbar fractures—results of the EOFTT study

AO Spine-DGOU Osteoporotic Fracture Classification System: Internal Validation by the AO Spine Knowledge Forum Trauma

A high hospital frailty risk score indicates an increased risk for complications following surgical treatment of proximal humerus fractures

Das Ovarialkarzinom: Score-Werte zur Definition von Risikopatientinnen

Orthogeriatric co-management in pelvic and acetabular fractures

Long-Term Follow-Up after Iliosacral Screw Fixation of Unstable Pelvic Ring Fractures

Diagnostics and early treatment in prehospital and emergency-room phase in suspicious pelvic ring fractures

Osteoporose in Deutschland

Operative versus conservative treatment in pelvic ring fractures with sacral involvement